Gao L, Bian F, Pan T, Jiang H, et al. Efficacy and safety of cofrogliptin once every 2 weeks in Chinese patients with type 2 diabetes: A randomized, double-blind, placebo-controlled, phase 3 trial. Diabetes Obes Metab 2024 Oct 21. doi: 10.1111/dom.16014.
PMID: 39434431